Epigenetic Regulation of the Renin–Angiotensin–Aldosterone System in Hypertension
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25158099 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Yoshimichi Takeda und 3 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology and Metabolism, Saiseikai Kanazawa Hospital, Kanazawa 920-0353, Japan. Hauptthemen laut MEDLINE: Renin-Angiotensin System, Epigenesis, Genetic, Hypertension, DNA Methylation. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 141 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Activation of the renin–angiotensin–aldosterone system (RAAS) plays an important pathophysiological role in hypertension. Increased mRNA levels of the angiotensinogen angiotensin-converting enzyme, angiotensin type 1 receptor gene, Agtr1a, and the aldosterone synthase gene, CYP11B2, have been reported in the heart, blood vessels, and kidneys in salt-sensitive hypertension. However, the mechanism of gene regulation in each component of the RAAS in cardiovascular and renal tissues is unclear. Epigenetic mechanisms, which are important for regulating gene expression, include DNA methylation, histone post-translational modifications, and microRNA (miRNA) regulation. A close association exists between low DNA methylation at CEBP-binding sites and increased AGT expression in visceral adipose tissue and the heart of salt-sensitive hypertensive rats. Several miRNAs influence AGT expression and are associated with cardiovascular diseases. Expression of both ACE and ACE2 genes is regulated by DNA methylation, histone modifications, and miRNAs. Expression of both angiotensinogen and CYP11B2 is reversibly regulated by epigenetic modifications and is related to salt-sensitive hypertension. The mineralocorticoid receptor (MR) exists in cardiovascular and renal tissues, in which many miRNAs influence expression and contribute to the pathogenesis of hypertension. Expression of the 11beta-hydroxysteroid dehydrogenase type 2 (HSD11B2) gene is also regulated by methylation and miRNAs. Epigenetic regulation of renal and vascular HSD11B2 is an important pathogenetic mechanism for salt-sensitive hypertension.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology and Metabolism, Saiseikai Kanazawa Hospital, Kanazawa 920-0353, Japan.
- Department of Hygiene, Graduate School of Medical Science, Kanazawa University, Kanazawa 921-8641, Japan.
- Institute of Liberal Arts and Science, Kanazawa University, Kanazawa 921-8641, Japan.
- Department of Health Promotion of Medicine of the Future, Graduate School of Medical Science, Kanazawa University, Kanazawa 921-8641, Japan.
- Hypertension Center, Asanogawa General Hospital, Kanazawa 910-8621, Japan.
ORCID-Profile: Yoshimichi Takeda
Zitieren
APA
Takeda, Y., Demura, M., Yoneda, T., & Takeda, Y. (2024). Epigenetic Regulation of the Renin–Angiotensin–Aldosterone System in Hypertension. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25158099
Vancouver
Takeda Y, Demura M, Yoneda T, Takeda Y. Epigenetic Regulation of the Renin–Angiotensin–Aldosterone System in Hypertension. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25158099
BibTeX
@article{Takeda2024,
author = {Takeda, Yoshimichi and Demura, Masashi and Yoneda, Takashi and Takeda, Yoshiyu},
title = {Epigenetic Regulation of the Renin–Angiotensin–Aldosterone System in Hypertension},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25158099}
}
EUVIMED